Expert consensus on dispensing management of intravenous infusion drugs for clinical trials in PIVAS
10.6039/j.issn.1001-0408.2025.01.01
- VernacularTitle:PIVAS临床试验用静脉输液类药品调配管理专家共识
- Author:
Xingchen YANG
1
;
Wenhuan FU
;
Donghui LAO
;
Jing ZHAO
;
Jianzhong ZHANG
Author Information
1. 上海中医药大学附属龙华医院药学部,上海 200032
- Collective Name:Pharmacy Intravenous Admixture Service Group,Hospital Pharmacy Professional Committee,Shanghai Pharmaceutical Association
- Publication Type:Journal Article
- Keywords:
PIVAS;
intravenous infusion drugs for clinical trials;
dispensing management;
expert consensus
- From:
China Pharmacy
2025;36(1):1-6
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To further standardize the dispensing management standard of intravenous infusion drugs for clinical trials in pharmacy intravenous admixture services (PIVAS),and provide reference for medical institutions to provide high-quality pharmaceutical services.METHODS Initiated by PIVAS Group,Hospital Pharmacy Professional Committee,Shanghai Pharmaceutical Association,jointly led by Longhua Hospital,Shanghai University of Traditional Chinese Medicine and Shanghai Geriatric Medical Center,a writing group was established by PIVAS experts from multiple medical institutions to discuss the basic requirements and dispensing process of intravenous infusion drugs for clinical trials in PIVAS.The experts from the leading unit sorted out,summarized,analyzed,fed back and revised the opinions,and finally reached Expert Consensus on Dispensing Management of Intravenous Infusion Drugs for Clinical Trials in PIVAS.RESULTS & CONCLUSIONS The main contents of this consensus include information management,operation process,fund management and document management of intravenous infusion drugs for clinical trials in PIVAS.This consensus establishes a more standardized model for dispensing management of intravenous infusion drugs for clinical trials in PIVAS,by standardizing clinical trail drug management operational procedures,accurately recording and preserving drug-related information,with the aim of achieving standardized and meticulous management of PIVAS's receipt of clinical trial drugs.
